ADVERTISEMENT
Conference Coverage
Exclusive Preview: Biosimilars for IMIDs: Availability, Affordability, and Interchangeability
07/10/2020
Dr Jonathan Kay, a professor of medicine and population & quantitative health sciences and the Timothy S. & Elaine L. Peterson Chair in rheumatology at University of Massachusetts Medical School, outlines why patients and physicians in the United States may not use biosimilars as readily as other countries in an on-demand session from Interdisciplinary Autoimmune Summit 2020.
For more coverage of the conference, visit the IAS 2020 Newsroom.
Stay In the Know
Autoimmune Newsletter
